SEC Form 4 · accession 0001127602-19-001695
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Omar Ishrak
Officer — Chairman & CEO · Director
Period of report
Jan 9, 2019
Accepted (ET)
Jan 9, 2019 · 12:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jan 9, 2019 | P | 12,000 | $84.045 | A | 570,722 | D | |
| Ordinary Shares | holding | — | — | — | 7,615 | I | 2017 GRAT | |
| Ordinary Shares | holding | — | — | — | 10,000 | I | 2018 GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.5 to $84.77, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4.
- F2This balance increased by 2,326 shares due to exempt transactions such as dividend reinvestment.